Role of Glutathione in Parkinson's Disease Pathophysiology and Therapeutic Potential of Polyphenols
Phytotherapy Research · 2024-12 · 38 (12) · 5567-5582
DOI: 10.1002/ptr.8342 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytotherapy Research, online erschienen am 17.09.2024. Verfasst von Chengu Niu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Residency Program, Rochester General Hospital, Rochester, New York, USA. Hauptthemen laut MEDLINE: Antioxidants, Brain, Glutathione, Neuroprotective Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 129 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Oxidative stress is recognized to have a central role in the initiation and progression of Parkinson's disease (PD). Within the brain, neurons are particularly sensitive to oxidation due in part to their weak intrinsic antioxidant defense. Theoretically, neurons mostly depend on neighboring astrocytes to provide antioxidant protection by supplying cysteine‐containing products for glutathione (GSH) synthesis. Astrocytes and neurons possess several amino acid transport systems for GSH and its precursors. Indeed, GSH is the most abundant intrinsic antioxidant in the central nervous system. The GSH depletion and/or alterations in its metabolism in the brain contribute to the pathogenesis of PD. Noteworthy, polyphenols possess potent antioxidant activity and can augment the GSH redox system. Numerous in vitro and in vivo studies have indicated that polyphenols exhibit potent neuroprotective effects in PD. Epidemiological studies have found an association between the consumption of dietary polyphenols and a lower PD risk. In this review, we summarize current knowledge on the biosynthesis and metabolism of GSH in the brain, with an emphasis on their contribution and therapeutic potential in PD. In particular, we focus on polyphenols that can increase brain GSH levels against PD. Furthermore, some current challenges and future perspectives for polyphenol‐based therapies are also discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Internal Medicine Residency Program, Rochester General Hospital, Rochester, New York, USA.
- The Institute of Medicine, Qiqihar Medical University, Qiqihar, China.
ORCID-Profile: Chengu Niu, Miaoxian Dong, Yingcai Niu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Niu, C., Dong, M., & Niu, Y. (2024). Role of Glutathione in Parkinson's Disease Pathophysiology and Therapeutic Potential of Polyphenols. Phytotherapy Research, 38(12), 5567-5582. https://doi.org/10.1002/ptr.8342
Vancouver
Niu C, Dong M, Niu Y. Role of Glutathione in Parkinson's Disease Pathophysiology and Therapeutic Potential of Polyphenols. Phytotherapy Research. 2024;38(12):5567-5582. doi:10.1002/ptr.8342
BibTeX
@article{Niu2024,
author = {Niu, Chengu and Dong, Miaoxian and Niu, Yingcai},
title = {Role of Glutathione in Parkinson's Disease Pathophysiology and Therapeutic Potential of Polyphenols},
journal = {Phytotherapy Research},
year = {2024},
volume = {38},
number = {12},
pages = {5567--5582},
doi = {10.1002/ptr.8342}
}
EUVIMED